Cargando…
Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is common among cancer patients treated with neurotoxic chemotherapy agents. Better knowledge on symptom clusters of CIPN may help improve symptom management in clinical practice. This study aimed to identify symptom clusters of CIPN and...
Autores principales: | Wang, Mian, Cheng, Hui Lin, Lopez, Violeta, Sundar, Raghav, Yorke, Janelle, Molassiotis, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882224/ https://www.ncbi.nlm.nih.gov/pubmed/31775665 http://dx.doi.org/10.1186/s12885-019-6352-3 |
Ejemplares similares
-
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019) -
Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019) -
Editorial: Quality of Life and Side Effects Management in Lung Cancer Treatment
por: Molassiotis, Alex, et al.
Publicado: (2021) -
Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial
por: Yorke, Janelle, et al.
Publicado: (2015) -
A Systematic Review and Meta-Analysis of the Effectiveness of Neuroprotectants for Paclitaxel-Induced Peripheral Neuropathy
por: Leen, Alisha Joan, et al.
Publicado: (2022)